Omnicare Company Profile (NYSE:OCR)

About Omnicare (NYSE:OCR)

Omnicare logoOmnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Residential & Long Term Care
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:OCR
  • CUSIP: 68190410
  • Web:
Average Prices:
  • 50 Day Moving Avg: $96.00
  • 200 Day Moving Avg: $87.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 21.28
  • P/E Growth: 0
  • Dividend Yield: 1.0%
  • Net Margins: 1.96%
  • Return on Equity: 5.37%
  • Return on Assets: 2.20%

Frequently Asked Questions for Omnicare (NYSE:OCR)

What is Omnicare's stock symbol?

Omnicare trades on the New York Stock Exchange (NYSE) under the ticker symbol "OCR."

How were Omnicare's earnings last quarter?

Omnicare, Inc. (NYSE:OCR) released its earnings results on Wednesday, February, 19th. The company reported $0.87 earnings per share for the quarter, missing analysts' consensus estimates of $0.90 by $0.03. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.59 billion. Omnicare had a return on equity of 5.37% and a net margin of 1.96%. View Omnicare's Earnings History.

Who are some of Omnicare's key competitors?

How do I buy Omnicare stock?

Shares of Omnicare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Omnicare's stock price today?

One share of Omnicare stock can currently be purchased for approximately $97.90.

MarketBeat Community Rating for Omnicare (NYSE OCR)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  177
MarketBeat's community ratings are surveys of what our community members think about Omnicare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Omnicare (NYSE:OCR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Omnicare (NYSE:OCR)
No equities research coverage for this company has been tracked by


Earnings History for Omnicare (NYSE:OCR)
Earnings by Quarter for Omnicare (NYSE:OCR)
Earnings History by Quarter for Omnicare (NYSE OCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2015Q215$1.02$1.02$1.68 billion$1.70 billionViewN/AView Earnings Details
4/29/2015Q1$1.01$1.02$1.64 billion$1.70 millionViewListenView Earnings Details
2/25/2015Q414$0.95$0.96$1.61 billion$1.63 billionViewListenView Earnings Details
10/24/2014Q314$0.92$0.94$1.60 billion$1.60 billionViewListenView Earnings Details
7/23/2014Q214$0.90$0.91$1.59 billion$1.60 billionViewListenView Earnings Details
4/23/2014Q114$0.90$0.91$1.55 billion$1.57 billionViewListenView Earnings Details
2/19/2014Q413$0.90$0.87$1.59 billion$1.54 billionViewListenView Earnings Details
10/23/2013Q313$0.90$0.91$1.55 billion$1.58 billionViewListenView Earnings Details
7/24/2013Q2 2013$0.87$0.90$1.54 billion$1.57 billionViewListenView Earnings Details
4/24/2013Q1 2013$0.85$0.90$1.54 billion$1.53 billionViewListenView Earnings Details
2/19/2013Q4 2012$0.85$0.86$1.51 billion$1.53 billionViewListenView Earnings Details
10/31/2012Q312$0.80$0.86$1.54 billion$1.50 billionViewN/AView Earnings Details
7/25/2012$0.68$0.83ViewN/AView Earnings Details
4/26/2012$0.68$0.81ViewN/AView Earnings Details
2/23/2012$0.57$0.58ViewN/AView Earnings Details
10/25/2011$0.53$0.54ViewN/AView Earnings Details
4/28/2011$0.50$0.52ViewN/AView Earnings Details
2/24/2011$0.51$0.46ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Omnicare (NYSE:OCR)
Current Year EPS Consensus Estimate: $4.15 EPS
Next Year EPS Consensus Estimate: $4.60 EPS


Current Dividend Information for Omnicare (NYSE:OCR)
Most Recent Dividend:6/30/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Omnicare (NYSE:OCR)

Dividend History by Quarter for Omnicare (NYSE OCR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Omnicare (NYSE:OCR)
Insider Trades by Quarter for Omnicare (NYSE:OCR)
Insider Trades by Quarter for Omnicare (NYSE:OCR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/5/2015Steven J HeyerDirectorBuy6,630$75.46$500,299.80View SEC Filing  
8/20/2014Amy WallmanDirectorSell5,672$63.84$362,100.48View SEC Filing  
5/6/2014Robert KraftCFOBuy1,500$60.00$90,000.00View SEC Filing  
4/30/2014Nitin SahneyCOOBuy10,000$58.49$584,900.00View SEC Filing  
5/24/2013Randall A CarpenterSVPSell17,587$45.85$806,363.95View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Omnicare (NYSE:OCR)
Latest Headlines for Omnicare (NYSE:OCR)
DateHeadline logoCan CVS Health Corp (CVS) Stock Stop Infuriating the Bulls? - August 7 at 11:19 AM logoContrasting Civitas Solutions (CIVI) and Omnicare (NYSE:OCR) - August 2 at 10:14 AM logoOmnicare (NYSE:OCR) vs. Capital Senior Living Corporation (CSU) Financial Contrast - August 2 at 8:26 AM logoContrasting Capital Senior Living Corporation (CSU) & Omnicare (OCR) - July 5 at 4:27 PM logoPharmaCord filling in top leadership team - June 27 at 7:05 PM logoExclusive: Former CEO starts new health care venture, brings jobs to Louisville - March 3 at 7:00 PM logoCVS Health Corporation in 4 Charts - February 4 at 5:49 AM logoCincinnati firm to pay $28M to settle kickback claims - October 26 at 9:57 AM logoOmnicare to pay $28 mln to settle charges it got kickbacks from Abbott Labs - October 17 at 11:44 AM logo$1 billion Medicare bust in Florida is biggest 'criminal health-care fraud case ever' - August 5 at 9:40 AM logoUPDATE 1-Deutsche Bank must face U.S. lawsuit over subprime disclosures - August 5 at 9:40 AM logoCVS Offers a Superb Bet on the Drug and Health Care Spending Boom - July 1 at 2:11 PM logoVentas Board Appoints James D. Shelton as Presiding Director - Business Wire (press release) - May 11 at 3:36 AM logoCVS Earnings Review : Revenues, EPS Increase - May 5 at 10:36 AM logoCVS Health Q1'16 Earnings Conference Call: Full Transcript - May 3 at 2:34 PM logoHealth care services company plans $25 million expansion, 400 new jobs - Louisville Business First - April 28 at 5:37 PM logoHealth care services company plans $25 million expansion, 400 new jobs - April 28 at 1:05 PM logoTransaction expected to be accretive to CVS Health's earnings and cash flow - March 3 at 10:00 AM logoNeed for Risk Management in Healthcare Will Expedite the Global Healthcare SCM Market Through 2020, says ... - Business Wire (press release) - March 1 at 4:35 PM logoCVS Earnings: Strong Performance Driven by Acquisitions and Growth In Specialty Business - February 12 at 9:58 AM logoNew Pharmacies And PBM Growth Boost CVS Health Profits - Forbes - February 9 at 9:56 AM logoWalgreens Boots to buy Rite Aid in $17.2 bn deal - October 27 at 6:51 PM logoTailwind Capital Expands its Healthcare Team - October 21 at 8:00 AM logoOMNICARE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - October 14 at 5:14 PM logoOMNICARE INC Financials - August 22 at 1:04 PM logoOMNICARE INC Files SEC form 8-K, Financial Statements and Exhibits - August 18 at 4:59 PM logoCare Capital Properties Set to Join the S&P MidCap 400 - August 12 at 5:39 PM logoOmnicare (OCR) is in Overbought Territory: What's Next? - August 12 at 8:02 AM logoOMNICARE INC Files SEC form 8-K, Other Events - August 6 at 5:26 PM logoCVS Eyes Specialty Pharmacy Opportunity through Acquisitions - August 6 at 11:06 AM logoMario Gabelli's Top 5 New Stock Buys of Q2 - August 5 at 6:23 PM logoLALT: A True Hedge ETF - July 31 at 11:34 AM logoOMNICARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - July 29 at 5:29 PM



Omnicare (OCR) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by Staff